Paul Blood

1.3k total citations
34 papers, 679 citations indexed

About

Paul Blood is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Paul Blood has authored 34 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 7 papers in Surgery. Recurrent topics in Paul Blood's work include Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Global Cancer Incidence and Screening (6 papers). Paul Blood is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Global Cancer Incidence and Screening (6 papers). Paul Blood collaborates with scholars based in Canada, United States and France. Paul Blood's co-authors include Lesley F. Degner, Michelle Lobchuk, Jeffrey A. Sloan, Charles Ludgate, Howard Pai, Andrea Bezjak, Michael Palmer, Joseph L. Pater, Ivo A. Olivotto and Brad H. Nelson and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Paul Blood

32 papers receiving 655 citations

Peers

Paul Blood
Jae Ill Zo South Korea
Monica Krishnan United States
P. Giraud France
Nina N. Sanford United States
Faith Mutale United States
Edward J. Kaplan United States
G. Dundas Canada
Jae Ill Zo South Korea
Paul Blood
Citations per year, relative to Paul Blood Paul Blood (= 1×) peers Jae Ill Zo

Countries citing papers authored by Paul Blood

Since Specialization
Citations

This map shows the geographic impact of Paul Blood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Blood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Blood more than expected).

Fields of papers citing papers by Paul Blood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Blood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Blood. The network helps show where Paul Blood may publish in the future.

Co-authorship network of co-authors of Paul Blood

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Blood. A scholar is included among the top collaborators of Paul Blood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Blood. Paul Blood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Lisa D., Nancy J. Nesslinger, Paul Blood, et al.. (2014). Tumor-associated autoantibodies correlate with poor outcome in prostate cancer patients treated with androgen deprivation and external beam radiation therapy. OncoImmunology. 3(6). e29243–e29243. 4 indexed citations
2.
Huang, Jin, Elaine S. Wai, Francis Lau, & Paul Blood. (2014). Palliative radiotherapy utilization for cancer patients at end of life in British Columbia: retrospective cohort study. BMC Palliative Care. 13(1). 49–49. 23 indexed citations
3.
Lefresne, Shilo, Ivo A. Olivotto, Howard Joe, Paul Blood, & Robert Olson. (2012). Impact of Quality Assurance Rounds in a Canadian Radiation Therapy Department. International Journal of Radiation Oncology*Biology*Physics. 85(3). e117–e121. 43 indexed citations
4.
Lemos, Mário L de, et al.. (2009). Use of combined androgen blockade for advanced prostate cancer in British Columbia. Journal of Oncology Pharmacy Practice. 16(2). 121–126. 3 indexed citations
6.
Palma, David A., Scott Tyldesley, Paul Blood, et al.. (2007). Pretreatment PSA Velocity as a Predictor of Disease Outcome Following Radical Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 67(5). 1425–1429. 14 indexed citations
7.
Truong, Pauline T., Eric Berthelet, Jan Lim, et al.. (2006). Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy.. PubMed. 13(3). 3139–46. 27 indexed citations
8.
Tyldesley, Scott, et al.. (2006). 120 Pre-treatment PSA velocity as a predictor of disease outcome following radical radiation therapy. Radiotherapy and Oncology. 80. S36–S36. 1 indexed citations
9.
Ludgate, Charles, Howard Pai, Jan Lim, et al.. (2005). Neoadjuvant hormone therapy and external-beam radiation for localized high-risk prostate cancer: The importance of PSA nadir before radiation. International Journal of Radiation Oncology*Biology*Physics. 62(5). 1309–1315. 24 indexed citations
10.
Greer, Peter B., Paul Blood, Yulia Dyachkova, et al.. (2005). Correction of systematic setup errors in prostate radiation therapy: How many images to perform?. Medical dosimetry. 30(2). 76–84. 19 indexed citations
11.
Scott, Shannon D., et al.. (2005). Mapping the journey of cancer patients through the health care system Part 3: An approach to staging. Canadian Oncology Nursing Journal. 15(1). 4–8. 1 indexed citations
12.
13.
Sloan, Jeff A., et al.. (2004). Mapping the journey of cancer patients through the health care system. Part 2: Methodological approaches and basic findings. Canadian Oncology Nursing Journal. 14(4). 224–227. 4 indexed citations
14.
Sloan, Jeff A., et al.. (2004). Cartographier le cheminement, dans le système de soins, des patients atteints de cancer. Partie 1: Élaboration de la question de recherche. Canadian Oncology Nursing Journal. 14(3). 188–191. 1 indexed citations
15.
Sloan, Jeff A., et al.. (2004). Mapping the journey of cancer patients through the health care system. Part 1: Developing the research question. Canadian Oncology Nursing Journal. 14(3). 183–186. 2 indexed citations
16.
Sloan, Jeff A., et al.. (2004). Cartographier le cheminement, dans le système de soins, des patients atteints de cancer. Partie II: Approches méthodologiques et résultats de base. Canadian Oncology Nursing Journal. 14(4). 228–232. 1 indexed citations
17.
Bezjak, Andrea, Peter Dixon, Michael Brundage, et al.. (2002). Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15). International Journal of Radiation Oncology*Biology*Physics. 54(3). 719–728. 117 indexed citations
18.
Bezjak, Andrea, Peter Dixon, Michael Brundage, et al.. (2001). Randomized study of single versus fractionated radiotherapy (RT) in the palliation of non-small cell lung cancer; NCIC CTG SC.15. International Journal of Radiation Oncology*Biology*Physics. 51(3). 20–20. 8 indexed citations
19.
Lobchuk, Michelle, et al.. (1997). Perceptions of symptom distress in lung cancer patients: I. Congruence between patients and primary family caregivers. Journal of Pain and Symptom Management. 14(3). 136–146. 101 indexed citations
20.
Blood, Paul, et al.. (1996). The role of palliative radiotherapy for brain metastases.. PubMed. 6 Suppl 1. 48–53. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026